Heartseed Inc. (TYO:219A)

Japan flag Japan · Delayed Price · Currency is JPY
1,879.00
-76.00 (-3.89%)
Mar 9, 2026, 3:30 PM JST
13.26%
Market Cap 42.95B
Revenue (ttm) 3.03B
Net Income (ttm) 592.50M
Shares Out 22.86M
EPS (ttm) 25.71
PE Ratio 73.08
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 526,600
Average Volume 407,570
Open 1,880.00
Previous Close 1,955.00
Day's Range 1,823.00 - 1,931.00
52-Week Range 1,343.00 - 4,385.00
Beta n/a
RSI 46.39
Earnings Date Feb 13, 2026

About Heartseed

Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2015
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 219A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.